1. 3000 Chemo-radiation (CRT) and mutation profile in stage III Non Small Cell Lung Cancer (NSCLC): An analysis of the prognostic value. Issue 3 (September 2015) Authors: Boros, A.; Lacroix, L.; Lacas, B.; Adam, J.; Pignon, J.P.; Caramella, C.; Planchard, D.; Levy, A.; Montpreville, V.; Deutsch, E.; Besse, B.; Pechoux, C. Le Journal: European journal of cancer Issue: Volume 51:Issue 3(2015:Feb.) Page Start: S595 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 3025 Prognostic value of PDL1 expression in stage III Non-Small Cell Lung Cancer (NSCLC) treated by chemo-radiotherapy (CRT). (September 2015) Authors: Adam, J.; Boros, A.; Lacas, B.; Lacroix, L.; Pignon, J.P.; Caramella, C.; Planchard, D.; Levy, A.; Besse, B.; Pechoux, C. Le Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S604 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EP-1158: Prognostic factors and role of neck dissection in N3 head and neck cancers treated with radiotherapy. (April 2018) Authors: Boros, A.; Blanchard, P.; Gorphe, P.; Breuskin, I.; Even, C.; Nguyen, F.; Deutsch, E.; Bidault, F.; Janot, F.; Temam, S.; Mirghani, H.; Tao, Y. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S649 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. EP-1245: A systematic review of dose-effect relationship in radiotherapy for head and neck plasmacytoma. (April 2018) Authors: Petit, C.; Mazeron, R.; Boros, A.; Rivera, S.; Blanchard, P.; Deutsch, E. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S688 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. EP-1249: Repeated low-dose radiation therapy in indolent Non-Hodgkin Lymphoma patients. (April 2018) Authors: Saleh, K.; Michot, J.M.; Schernberg, A.; Danu, A.; Lazarovici, J.; Ghez, D.; Girinsky, T.; Khalife-Saleh, N.; Mazeron, R.; Ribrag, V.; Boros, A. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S690 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PRELIMINARY RESULTS OF A QUALITY CONTROL STUDY ON INVOLVED NODE RADIOTHERAPY IN THE EORTC/LYSA/FIL H10 TRIAL ON STAGES I/II HODGKIN LYMPHOMA. (12th June 2019) Authors: Aleman, B.M.; Ricardi, U.; van der Maazen, R.W.; Meijnders, P.; Beijert, M.; Boros, A.; Izar, F.; Janus, C.P.; Levis, M.; Martin, V.; Specht, L.; Corning, C.; Clementel, E.; Fortpied, C.; Raemaekers, J.M.; Andre, M.P.; Federico, M.; Girinsky, T. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 487 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PV-0044: Is involved-node radiotherapy for Hodgkin lymphoma safe in routine?. (May 2017) Authors: Boros, A.; Sun, R.; Arfi Rouche, J.; Lazarovici, J.; Ghez, D.; Michot, J.M.; Beaudré, A.; Danu, A.; Bosq, J.; Ribrag, V.; Mazeron, R. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗